Literature DB >> 17283518

[Guidelines for the diagnosis and treatment of liver fibrosis in integrative medicine practice].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17283518

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN： 1007-3418


× No keyword cloud information.
  6 in total

1.  Effects of Danggui Buxue Decoction () on lipid peroxidation and MMP-2/9 activities of fibrotic liver in rats.

Authors:  Yuan Chen; Qian Chen; Jing Lu; Feng-hua Li; Yan-yan Tao; Cheng-hai Liu
Journal:  Chin J Integr Med       Date:  2010-01-18       Impact factor: 1.978

2.  The Score Model Containing Chinese Medicine Syndrome Element of Blood Stasis Presented a Better Performance Compared to APRI and FIB-4 in Diagnosing Advanced Fibrosis in Patients with Chronic Hepatitis B.

Authors:  Xiao-Ling Chi; Mei-Jie Shi; Huan-Ming Xiao; Yu-Bao Xie; Gao-Shu Cai
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-20       Impact factor: 2.629

3.  A national survey of Chinese medicine doctors and clinical practice guidelines in China.

Authors:  Mengyu Liu; Chi Zhang; Qinglin Zha; Wei Yang; Ya Yuwen; Linda Zhong; Zhaoxiang Bian; Xuejie Han; Aiping Lu
Journal:  BMC Complement Altern Med       Date:  2017-09-06       Impact factor: 3.659

4.  Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes.

Authors:  Mei-Jie Shi; Huan-Ming Xiao; Yu-Bao Xie; Jun-Min Jiang; Peng-Tao Zhao; Gao-Shu Cai; Ying-Xian Li; Sheng Li; Chao-Zhen Zhang; Min-Ling Cao; Qu-Bo Chen; Zhi-Jian Tan; Heng-Jun Gao; Xiao-Ling Chi
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-31       Impact factor: 2.629

5.  The chinese herbal decoction danggui buxue tang inhibits angiogenesis in a rat model of liver fibrosis.

Authors:  Jing Lv; Zhimin Zhao; Yuan Chen; Qinglan Wang; Yanyan Tao; Li Yang; Tai-Ping Fan; Chenghai Liu
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-29       Impact factor: 2.629

Review 6.  Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis.

Authors:  Shu Dong; Qi-Long Chen; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-28       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.